Hlavní stránka
Philips – kliknutím sem přejdete na domovskou stránku

Termíny pro vyhledávání

ELCA Coronary laser atherectomy catheter

ELCA

Coronary laser atherectomy catheter

Najít podobné výrobky

ELCA coronary laser atherectomy catheters are designed to cross, prepare and treat the most complex coronary lesions. This non-mechanical atherectomy catheter can be delivered over any .014” wire and can de-bulk and modify plaque of multiple morphologies and is approved for the broadest range of coronary indications in atherectomy.

Kontaktujte nás

Media Gallery

Features
Optimal vessel preparation
Optimal vessel preparation

Optimal vessel preparation

Can be used with any coronary .014” wire and multiple wires in place.
Two-thirds vessel sizing rule
Two-thirds vessel sizing rule

Two-thirds vessel sizing rule

Two-thirds vessel sizing rule for predictable outcomes.
Treatment versatility

Treatment versatility

Adjustable laser energy settings to satisfy many clinical needs.
Automatic shut-off feature

Automatic shut-off feature

Automatic shut-off feature for advanced patient safety.
Saline infusion

Saline infusion

Saline infusion improves safety outcomes.¹
Slow advancement

Slow advancement

Slow advancement increases luminal gain.²
  • 1. Tcheng, J.E. et al. (1995). Development of a New Technique for Reducing Pressure Pulse Generation During 308-nm Excimer Laser Coronary Angioplasty. Catheterization and Cardiovascular Diagnosis. 34, 15-22.
  • 2. Topaz, On, et al, 2001. Optimal Spaced Excimer Laser Coronary Catheters Performance Analysis, Journal of Clinical Laser Medicine and Surgery, Vol 19, Issue 1, 9-14.
  • ELCA important safety information
  • Indications: The laser catheters are intended for use either as a stand-alone modality or in conjunction with percutaneous transluminal coronary balloon angioplasty (PTCA) in patients who are acceptable candidates for coronary artery bypass graft (CABG) surgery. The following indications for use, contraindications and warnings have been established through multicenter clinical trials. The Philips CVX-300 Excimer laser system and the multi-fiber laser catheter models are safe and effective for the following indications: occluded saphenous vein bypass grafts, ostial lesions, long lesions (greater than 20mm in length), moderately calcified stenosis, total occlusions traversable by a guidewire, lesions which previously failed balloon angioplasty, restenosis in 316L stainless steel stents, prior to the administration of intravascular brachytherapy. These lesions must be traversable by a guidewire and composed of atherosclerotic plaque and/or calcified material. The lesions should be well defined by angiography.
  • Contraindications: Lesion is in an unprotected left main artery. Lesion is beyond acute bends or is in a location within the coronary anatomy where the catheter cannot traverse. Guidewire cannot be passed through the lesion. Lesion is located within a bifurcation. Patient is not an acceptable candidate for bypass graft surgery.
  • Potential adverse events: Use of the Philips CVX-300 Excimer laser system may contribute to the following complications: dissection of the arterial wall, perforation, acute reclosure, embolization, aneurysm formation, spasm, coronary artery bypass graft surgery, thrombus, myocardial infarction, arrhythmia, filling defects, death. No long term adverse effects of ELCA are known at this time.
  • Risks: The primary endpoint defined in the laser angioplasty of restenosis stents (LARS) randomized trial was the absence of major adverse cardiac events (MACE) at 6 months: Death; myocardial infarction; coronary artery bypass surgery. Procedural complications include: any dissection, acute thrombus, haziness, no reflow, arrhythmia, acute vessel closure, occlusion of side branch, occlusion non-target, coronary spasm, coronary embolism, coronary perforation, laser/stent damage, balloon/stent damage, and other serious.
  • Caution: Federal law restricts this device to sale by or on the order of a physician.

Media Gallery

Features
Optimal vessel preparation
Optimal vessel preparation

Optimal vessel preparation

Can be used with any coronary .014” wire and multiple wires in place.
Two-thirds vessel sizing rule
Two-thirds vessel sizing rule

Two-thirds vessel sizing rule

Two-thirds vessel sizing rule for predictable outcomes.
Treatment versatility

Treatment versatility

Adjustable laser energy settings to satisfy many clinical needs.
Automatic shut-off feature

Automatic shut-off feature

Automatic shut-off feature for advanced patient safety.
Saline infusion

Saline infusion

Saline infusion improves safety outcomes.¹
Slow advancement

Slow advancement

Slow advancement increases luminal gain.²

Specifikace

0.9mm X-80
0.9mm X-80
Model number
  • 110-004
Guidewire compatibility
  • 0.014 in
Guide catheter compatibility
  • 6 F
Minimum vessel diameter
  • 2.0 mm
Max tip outer diameter
  • 0.038 in
Max shaft outer diameter
  • 0.049 in
Working length
  • 130 cm
Fluence
  • 30-80 mJ / mm²
Repetition rate
  • 25-80 Hz
Laser on / off time
  • 10 / 5 sec
1.4mm
1.4mm
Model number
  • 114-009
Guidewire compatibility
  • 0.014 in
Guide catheter compatibility
  • 6 / 7 F
Minimum vessel diameter
  • 2.2 mm
Max tip outer diameter
  • 0.057 in
Max shaft outer diameter
  • 0.062 in
Working length
  • 130 cm
Fluence
  • 30-60 mJ / mm²
Repetition rate
  • 25-40 Hz
Laser on / off time
  • 5 / 10 sec
1.7mm
1.7mm
Model number
  • 117-016
Guidewire compatibility
  • 0.014 in
Guide catheter compatibility
  • 7 F
Minimum vessel diameter
  • 2.5 mm
Max tip outer diameter
  • 0.069 in
Max shaft outer diameter
  • 0.072 in
Working length
  • 130 cm
Fluence
  • 30-60 mJ / mm²
Repetition rate
  • 25-40 Hz
Laser on / off time
  • 5 / 10 sec
2.0mm
2.0mm
Model number
  • 120-009
Guidewire compatibility
  • 0.014 in
Guide catheter compatibility
  • 8 F
Minimum vessel diameter
  • 3 mm
Max tip outer diameter
  • 0.080 in
Max shaft outer diameter
  • 0.084 in
Working length
  • 130 cm
Fluence
  • 30-60 mJ / mm²
Repetition rate
  • 25-40 Hz
Laser on / off time
  • 5 / 10 sec

Documentation

Brochure (1)

Brochure

  • 1. Tcheng, J.E. et al. (1995). Development of a New Technique for Reducing Pressure Pulse Generation During 308-nm Excimer Laser Coronary Angioplasty. Catheterization and Cardiovascular Diagnosis. 34, 15-22.
  • 2. Topaz, On, et al, 2001. Optimal Spaced Excimer Laser Coronary Catheters Performance Analysis, Journal of Clinical Laser Medicine and Surgery, Vol 19, Issue 1, 9-14.
  • ELCA important safety information
  • Indications: The laser catheters are intended for use either as a stand-alone modality or in conjunction with percutaneous transluminal coronary balloon angioplasty (PTCA) in patients who are acceptable candidates for coronary artery bypass graft (CABG) surgery. The following indications for use, contraindications and warnings have been established through multicenter clinical trials. The Philips CVX-300 Excimer laser system and the multi-fiber laser catheter models are safe and effective for the following indications: occluded saphenous vein bypass grafts, ostial lesions, long lesions (greater than 20mm in length), moderately calcified stenosis, total occlusions traversable by a guidewire, lesions which previously failed balloon angioplasty, restenosis in 316L stainless steel stents, prior to the administration of intravascular brachytherapy. These lesions must be traversable by a guidewire and composed of atherosclerotic plaque and/or calcified material. The lesions should be well defined by angiography.
  • Contraindications: Lesion is in an unprotected left main artery. Lesion is beyond acute bends or is in a location within the coronary anatomy where the catheter cannot traverse. Guidewire cannot be passed through the lesion. Lesion is located within a bifurcation. Patient is not an acceptable candidate for bypass graft surgery.
  • Potential adverse events: Use of the Philips CVX-300 Excimer laser system may contribute to the following complications: dissection of the arterial wall, perforation, acute reclosure, embolization, aneurysm formation, spasm, coronary artery bypass graft surgery, thrombus, myocardial infarction, arrhythmia, filling defects, death. No long term adverse effects of ELCA are known at this time.
  • Risks: The primary endpoint defined in the laser angioplasty of restenosis stents (LARS) randomized trial was the absence of major adverse cardiac events (MACE) at 6 months: Death; myocardial infarction; coronary artery bypass surgery. Procedural complications include: any dissection, acute thrombus, haziness, no reflow, arrhythmia, acute vessel closure, occlusion of side branch, occlusion non-target, coronary spasm, coronary embolism, coronary perforation, laser/stent damage, balloon/stent damage, and other serious.
  • Caution: Federal law restricts this device to sale by or on the order of a physician.

By clicking on the link, you will be leaving the official Royal Philips Healthcare ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.

I understand